TRINITY BIOTECH PLC (TRIB) Form 6-K — Jun 5, 2026
Trinity Biotech plc disclosed that it has agreed with its lender, Perceptive Credit Holdings III, LP, to capitalize the interest payable for May 2026. This means the interest will be added to the principal balance outstanding rather than paid in cash, indicating a cash conservation measure. Additionally, Perceptive has granted a limited waiver regarding Section 8.15 of the credit agreement for June 2026.
Key figures
- Waiver period
- June 2026
- Interest capitalization period
- May 2026
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.